[Personal experience with the treatment of recurrent varices of the lower limbs].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 610957)

Published in Chir Ital on December 01, 1977

Authors

L Frontini, C Pozzi, P Rona

Articles by these authors

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol (2002) 3.75

On the origin and domestication history of Barley (Hordeum vulgare). Mol Biol Evol (2000) 2.94

Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1984) 2.26

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol (1998) 2.21

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol (1997) 1.94

The barley Hooded mutation caused by a duplication in a homeobox gene intron. Nature (1995) 1.86

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1989) 1.83

A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74

Cloning, mapping and expression analysis of barley MADS-box genes. Plant Mol Biol (2000) 1.72

Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics. Ann Thorac Surg (1999) 1.49

Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer (1995) 1.35

Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. Int J Biol Markers (2004) 1.35

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer (2004) 1.20

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study. J Clin Oncol (1994) 1.15

Unexpected dilatation of the common bile duct after methyl tertiary butyl ether (MTBE) in rabbits. Possible implications to findings in man. Gut (1989) 1.08

An AFLP-based procedure for the efficient mapping of mutations and DNA probes in barley. Genetics (1998) 1.07

Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis (1999) 1.04

Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer (2003) 1.04

Molecular linkage maps of Vitis vinifera L. and Vitis riparia Mchx. Theor Appl Genet (2002) 1.02

A reconsideration of the domestication geography of tetraploid wheats. Theor Appl Genet (2005) 1.01

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J Intern Med (2013) 1.00

Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clin Exp Immunol (1991) 0.98

A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. Br J Cancer (2001) 0.96

Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. Br Med J (Clin Res Ed) (1985) 0.95

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer (1999) 0.95

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer (1998) 0.94

Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma. Proc Eur Dial Transplant Assoc (1980) 0.94

Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italien Renal Immunopathology Group. Clin Nephrol (1987) 0.92

Chemokine expression by subchondral bone marrow stromal cells isolated from osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Clin Exp Immunol (1999) 0.91

Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy. Clin Nephrol (1992) 0.90

Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1999) 0.90

Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators. Br J Cancer (2000) 0.89

The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transplant (2007) 0.87

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Lung Cancer (2001) 0.86

Light chain deposition disease of the kidney. Morphological aspects in 24 patients. Virchows Arch (1994) 0.85

[Traumatic rupture of the diaphragm caused by closed injury]. Chir Ital (1978) 0.85

Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer (1999) 0.85

Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group. Clin Nephrol (1987) 0.85

Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment. Calcif Tissue Int (1993) 0.84

Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial. J Nephrol (2000) 0.84

Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer. Ann Oncol (1999) 0.83

Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. Clin Nephrol (1983) 0.83

Lack of IgA antineutrophil cytoplasmic antibodies in Henoch-Schönlein purpura and IgA nephropathy. Clin Immunol Immunopathol (1994) 0.82

Idiopathic membranous nephropathy in the elderly. Nephrol Dial Transplant (1993) 0.81

Role of proteinuria reduction in the progression of IgA nephropathy. Ren Fail (2001) 0.81

Relapsing haemolytic-uraemic syndrome after organic solvent sniffing. Lancet (1983) 0.81

Different pattern of cytokine production and mRNA expression by lymphoid and non-lymphoid cells isolated from human palatine tonsil. Int J Clin Lab Res (1998) 0.80

A phase II study of tamoxifen in hormone-resistant metastatic prostate cancer: possible relation with prolactin secretion. Anticancer Res (2005) 0.80

Oral etoposide as second-line chemotherapy for colorectal cancer: a GISCAD study. Gruppo Italiano Studio Carcinomi Apparato Digerente. J Chemother (1995) 0.80

Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. Int J Biol Markers (2005) 0.80

Utility of immunofluorescence of urine sediment for identifying patients with renal disease due to monoclonal gammopathies. Am J Kidney Dis (1991) 0.80

Increasing doses of 5-fluorouracil and high-dose folinic acid in the treatment of metastatic colorectal cancer. Tumori (1999) 0.79

Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers. Ann Oncol (2000) 0.79

Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant (1998) 0.79

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer. Br J Cancer (1990) 0.79

Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Ann Oncol (2003) 0.79

Primary antiphospholipid antibody syndrome with membranous obstruction of the inferior vena cava--successful PTA and thrombolytic therapy. Nephrol Dial Transplant (1998) 0.79

Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study. Br J Cancer (2001) 0.78

[Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results]. Minerva Nefrol (1981) 0.78

Osteoblastic cell lines are not susceptible to HIV-1 infection. Boll Soc Ital Biol Sper (1996) 0.78

Vinorelbine as single agent in pretreated patients with advanced breast cancer. Tumori (1994) 0.78

Clinical significance of autoantibodies to myeloperoxidase in vasculitic syndromes. Contrib Nephrol (1991) 0.78

A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Ann Oncol (2000) 0.78

The effect of multiple blood conservation techniques on donor blood exposure in adult coronary and valve surgery performed with a membrane oxygenator: a multivariate analysis on 1310 patients. J Card Surg (1995) 0.77

Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature. Anticancer Res (2000) 0.77

Expression profiling of genes involved in the formation of aroma in two peach genotypes. Plant Biol (Stuttg) (2012) 0.77

CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake. Biochim Biophys Acta (2010) 0.77

ANCA with specificity for lactoferrin in systemic lupus erythematosus (SLE). Adv Exp Med Biol (1993) 0.77

Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells. Eur J Immunogenet (1993) 0.77

GBV-C/HGV infection in end-stage renal disease: a serological and virological survey. J Nephrol (2000) 0.77

[Prevalence of Bartonella henselae in stray and domestic cats in different Italian areas: evaluation of the potential risk of transmission of Bartonella to humans]. Parassitologia (2004) 0.77

Sodium kinetics across dialysis membranes. Nephron (1984) 0.76

Molecular identification and in vitro antifungal susceptibilities of 28 zygomycetes isolates: FIMUA-ECMM survey of zygomycosis in Italy. J Chemother (2009) 0.76

Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil. Br J Cancer (2004) 0.76

Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseases. Am J Kidney Dis (1993) 0.75

New therapeutic approaches in primary IgA nephropathy. Adv Nephrol Necker Hosp (1999) 0.75

Toxicity in man due to stain removers containing 1,2-dichloropropane. Br J Ind Med (1985) 0.75

Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen. Br J Cancer (2002) 0.75

Terguride for dyskinesias. Neurology (1993) 0.75

Steroids and immunoglobulin A nephritis. Kidney Int (2006) 0.75

The treatment of IgA nephropathy. J Nephrol (2000) 0.75

Light chain nephropathy: histological and clinical aspects in 15 cases. Nephrol Dial Transplant (1988) 0.75

Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma: 6-year follow-up. Oncology (2004) 0.75

High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer. Ann Oncol (1997) 0.75

Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer. Oncology (1993) 0.75

[New drugs for colorectal cancer: UFT]. Tumori (2001) 0.75

[A case of primary duodenal cancer. Diagnostic and therapeutic considerations]. Radiol Med (1983) 0.75

[Adjuvant therapy of colon cancer. State of the art and future perspectives]. Tumori (1999) 0.75

Phase II study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer. Tumori (1999) 0.75

[Technical considerations and preliminary experiences in the use of a mechanical suture apparatus in anastomoses of the digestive tract]. Chir Ital (1981) 0.75

[Cancer of the gastric stump after gastroduodenal resection for peptic ulcer disease. Our experience]. Minerva Chir (1986) 0.75

[Multiple primary neoplasms]. Chir Ital (1982) 0.75

The favorable prognostic significance of surgery-induced hyperprolactinemia in node-positive breast cancer patients: ten-year disease-free survival results. Int J Biol Markers (2005) 0.75

A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer. Ann Oncol (1999) 0.75

Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. Int J Biol Markers (2017) 0.75

[Early diagnostic laparotomy in patients with multiple injuries (apropos of 125 cases)]. Chir Ital (1977) 0.75

[Postoperative hyperamylasemia in surgery of the biliary tract (clinical contribution)]. Chir Ital (1980) 0.75

Diagnostic significance and antigen specificity of antineutrophil cytoplasmic antibodies in renal diseases. A prospective multicentre study. Italian Group of Renal Immunopathology. Nephrol Dial Transplant (1994) 0.75